Cargando…
Reactivation of hepatitis B virus infection in patients with hematologic disorders
Hepatitis B reactivation is the reappearance or rise of hepatitis B virus (HBV) DNA in patients with past or chronic HBV infection, usually occurring in the context of immunosuppression. HBV reactivation has been most commonly reported in patients with hematologic disorders, with potentially serious...
Autores principales: | Wang, Bo, Mufti, Ghulam, Agarwal, Kosh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ferrata Storti Foundation
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6395346/ https://www.ncbi.nlm.nih.gov/pubmed/30733266 http://dx.doi.org/10.3324/haematol.2018.210252 |
Ejemplares similares
-
Tenofovir alafenamide in the treatment of chronic hepatitis B virus
infection: rationale and clinical trial evidence
por: Byrne, Ruth, et al.
Publicado: (2018) -
Health inequalities in the management of chronic hepatitis B virus infection in patients from sub-Saharan Africa in high-income countries
por: Mitchell, Tim, et al.
Publicado: (2022) -
Screening for Hepatocellular Carcinoma in Chronic Hepatitis B: An Update
por: Lok, James, et al.
Publicado: (2021) -
Prevention and management of hepatitis B virus reactivation in patients with hematological malignancies in the targeted therapy era
por: Mak, Joyce Wing Yan, et al.
Publicado: (2023) -
Hepatitis B reactivation among 1962 patients with hematological malignancy in Taiwan
por: Chen, Chien-Yuan, et al.
Publicado: (2018)